Sonnet BioTherapeutics Holdings, Inc. (SONN): Price and Financial Metrics
SONN Price/Volume Stats
| Current price | $1.16 | 52-week high | $16.00 |
| Prev. close | $1.17 | 52-week low | $1.08 |
| Day low | $1.15 | Volume | 15,500 |
| Day high | $1.18 | Avg. volume | 96,783 |
| 50-day MA | $1.28 | Dividend yield | N/A |
| 200-day MA | $2.85 | Market Cap | 3.66M |
SONN Stock Price Chart Interactive Chart >
Sonnet BioTherapeutics Holdings, Inc. (SONN) Company Bio
Sonnet BioTherapeutics Holdings, Inc. operates as a clinical stage biotechnology company. The Company develops fully human albumin binding technology that helps the development of innovative targeted biologic drugs with enhanced single-or bi-specific mechanisms. Sonnet BioTherapeutics Holdings serves customers in the United States.
SONN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SONN Price Returns
| 1-mo | -10.08% |
| 3-mo | -22.15% |
| 6-mo | -44.76% |
| 1-year | -91.16% |
| 3-year | -99.80% |
| 5-year | -99.99% |
| YTD | -20.55% |
| 2024 | -89.51% |
| 2023 | -93.12% |
| 2022 | -80.12% |
| 2021 | -81.48% |
| 2020 | -85.46% |